Clinical Outcomes and Healthcare Resource Utilization in a Real-World Population Reflecting the DAPA-CKD Trial Participants

INTRODUCTION: The DAPA-CKD trial assessed dapagliflozin in patients with chronic kidney disease (CKD) with or without type 2 diabetes (T2D). To aid interpretation of results, renal and cardiovascular outcomes plus healthcare resource utilization (HCRU) and costs were assessed in a real-world populat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Adv Ther
Autori principali: Olufade, Tope, Lamerato, Lois, Sánchez, Juan José García, Jiang, Like, Huang, Joanna, Nolan, Stephen, Rangaswami, Janani
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Healthcare 2021
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889671/
https://ncbi.nlm.nih.gov/pubmed/33474707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01609-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi